Author:
Caviedes Pablo,Caviedes Raúl,Segura-Aguilar Juan
Publisher
Springer International Publishing
Reference60 articles.
1. Aguirre, P., Urrutia, P., Tapia, V., Villa, M., Paris, I., Segura-Aguilar, J., & Núñez, M. T. (2012). The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1. Biometals, 25(4), 795–803.
2. Allen, D. D., Caviedes, R., Cárdenas, A. M., Shimahara, T., Segura-Aguilar, J., & Caviedes, P. (2005). Cell lines as in vitro models for drug screening and toxicity studies. Drug Development and Industrial Pharmacy, 31(8), 747–758.
3. Arriagada, C., Salazar, J., Shimahara, T., Caviedes, R., & Caviedes, P. (2002). An immortalized neuronal cell line derived from the substantia nigra of an adult rat: Application to cell transplant therapy. In E. Ronken & G. van Scharrenburg (Eds.), Parkinson’s disease (pp. 120–132). IOS Press. ISBN 1 58603 207 0.
4. Arriagada, C., Paris, I., Sánchez de las Matas, M. J., Martínez-Alvarado, P., Graumann, R., Cárdenas, S., Castañeda, P., Pérez-Pastene, C., Olea Azar, C., Couve, E., Herrero, M. T., Caviedes, P., & Segura-Aguilar, J. (2004). Neurotoxic effects of leukoaminochrome o-semiquinone radical on RCSN-3 cells: Mitochondrial damage, necrosis, and hydroxyl radical formation. Neurobiology of Disease, 16, 468–477.
5. Blandini, F., & Armentero, M. T. (2012). Animal models of Parkinson’s disease. The FEBS Journal, 279(7), 1156–1166.